ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Intramuscular Vaccine Adjuvants Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-31O13095
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Intramuscular Vaccine Adjuvants Market Research Report 2023
BUY CHAPTERS

Global Intramuscular Vaccine Adjuvants Market Research Report 2025

Code: QYRE-Auto-31O13095
Report
January 2025
Pages:90
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
GSK
Dynavax Technologies
Novavax Inc
Agenus
Croda International
SEPPIC
Oz Biosciences
Phibro Animal Health
Associated British Foods
InvivoGen
Merck KGaA
CSL Limited

Intramuscular Vaccine Adjuvants Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Intramuscular Vaccine Adjuvants Market

Intramuscular Vaccine Adjuvants Market

The global market for Intramuscular Vaccine Adjuvants was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Intramuscular Vaccine Adjuvants is used for Intramuscular injection of Vaccine Adjuvants. A vaccine adjuvant is any material which is incorporated with a vaccine for the purpose of enhancing the immune response of the vaccine. An adjuvanted vaccine will tend to have a higher, earlier, and longer-lasting immune response than a non-adjuvanted vaccine.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Intramuscular Vaccine Adjuvants, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intramuscular Vaccine Adjuvants.
The Intramuscular Vaccine Adjuvants market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Intramuscular Vaccine Adjuvants market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intramuscular Vaccine Adjuvants manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Intramuscular Vaccine Adjuvants Market Report

Report Metric Details
Report Name Intramuscular Vaccine Adjuvants Market
CAGR 5%
Segment by Type
Segment by Application
  • Research Applications
  • Commercial Applications
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company GSK, Dynavax Technologies, Novavax, Agenus, Croda International, Seppic, OZ Biosciences, Phibro Animal Health, Associated British Foods, InvivoGen, Merck KGaA, CSL Limited
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Intramuscular Vaccine Adjuvants manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Intramuscular Vaccine Adjuvants in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Intramuscular Vaccine Adjuvants Market report?

Ans: The main players in the Intramuscular Vaccine Adjuvants Market are GSK, Dynavax Technologies, Novavax, Agenus, Croda International, Seppic, OZ Biosciences, Phibro Animal Health, Associated British Foods, InvivoGen, Merck KGaA, CSL Limited

What are the Application segmentation covered in the Intramuscular Vaccine Adjuvants Market report?

Ans: The Applications covered in the Intramuscular Vaccine Adjuvants Market report are Research Applications, Commercial Applications

What are the Type segmentation covered in the Intramuscular Vaccine Adjuvants Market report?

Ans: The Types covered in the Intramuscular Vaccine Adjuvants Market report are Infectious Diseases, Cancer, Others

Recommended Reports

Vaccine Types

Vaccine Equipment

Combined & Specialized Vaccines

1 Intramuscular Vaccine Adjuvants Market Overview
1.1 Product Definition
1.2 Intramuscular Vaccine Adjuvants by Type
1.2.1 Global Intramuscular Vaccine Adjuvants Market Value Comparison by Type (2024 VS 2031)
1.2.2 Infectious Diseases
1.2.3 Cancer
1.2.4 Others
1.3 Intramuscular Vaccine Adjuvants by Application
1.3.1 Global Intramuscular Vaccine Adjuvants Market Value by Application (2024 VS 2031)
1.3.2 Research Applications
1.3.3 Commercial Applications
1.4 Global Intramuscular Vaccine Adjuvants Market Size Estimates and Forecasts
1.4.1 Global Intramuscular Vaccine Adjuvants Revenue 2020-2031
1.4.2 Global Intramuscular Vaccine Adjuvants Sales 2020-2031
1.4.3 Global Intramuscular Vaccine Adjuvants Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Intramuscular Vaccine Adjuvants Market Competition by Manufacturers
2.1 Global Intramuscular Vaccine Adjuvants Sales Market Share by Manufacturers (2020-2025)
2.2 Global Intramuscular Vaccine Adjuvants Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Intramuscular Vaccine Adjuvants Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Intramuscular Vaccine Adjuvants, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Intramuscular Vaccine Adjuvants, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Intramuscular Vaccine Adjuvants, Product Type & Application
2.7 Global Key Manufacturers of Intramuscular Vaccine Adjuvants, Date of Enter into This Industry
2.8 Global Intramuscular Vaccine Adjuvants Market Competitive Situation and Trends
2.8.1 Global Intramuscular Vaccine Adjuvants Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Intramuscular Vaccine Adjuvants Players Market Share by Revenue
2.8.3 Global Intramuscular Vaccine Adjuvants Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Intramuscular Vaccine Adjuvants Market Scenario by Region
3.1 Global Intramuscular Vaccine Adjuvants Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Intramuscular Vaccine Adjuvants Sales by Region: 2020-2031
3.2.1 Global Intramuscular Vaccine Adjuvants Sales by Region: 2020-2025
3.2.2 Global Intramuscular Vaccine Adjuvants Sales by Region: 2026-2031
3.3 Global Intramuscular Vaccine Adjuvants Revenue by Region: 2020-2031
3.3.1 Global Intramuscular Vaccine Adjuvants Revenue by Region: 2020-2025
3.3.2 Global Intramuscular Vaccine Adjuvants Revenue by Region: 2026-2031
3.4 North America Intramuscular Vaccine Adjuvants Market Facts & Figures by Country
3.4.1 North America Intramuscular Vaccine Adjuvants Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Intramuscular Vaccine Adjuvants Sales by Country (2020-2031)
3.4.3 North America Intramuscular Vaccine Adjuvants Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Intramuscular Vaccine Adjuvants Market Facts & Figures by Country
3.5.1 Europe Intramuscular Vaccine Adjuvants Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Intramuscular Vaccine Adjuvants Sales by Country (2020-2031)
3.5.3 Europe Intramuscular Vaccine Adjuvants Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Intramuscular Vaccine Adjuvants Market Facts & Figures by Region
3.6.1 Asia Pacific Intramuscular Vaccine Adjuvants Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Intramuscular Vaccine Adjuvants Sales by Region (2020-2031)
3.6.3 Asia Pacific Intramuscular Vaccine Adjuvants Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Intramuscular Vaccine Adjuvants Market Facts & Figures by Country
3.7.1 Latin America Intramuscular Vaccine Adjuvants Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Intramuscular Vaccine Adjuvants Sales by Country (2020-2031)
3.7.3 Latin America Intramuscular Vaccine Adjuvants Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Intramuscular Vaccine Adjuvants Market Facts & Figures by Country
3.8.1 Middle East and Africa Intramuscular Vaccine Adjuvants Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Intramuscular Vaccine Adjuvants Sales by Country (2020-2031)
3.8.3 Middle East and Africa Intramuscular Vaccine Adjuvants Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Intramuscular Vaccine Adjuvants Sales by Type (2020-2031)
4.1.1 Global Intramuscular Vaccine Adjuvants Sales by Type (2020-2025)
4.1.2 Global Intramuscular Vaccine Adjuvants Sales by Type (2026-2031)
4.1.3 Global Intramuscular Vaccine Adjuvants Sales Market Share by Type (2020-2031)
4.2 Global Intramuscular Vaccine Adjuvants Revenue by Type (2020-2031)
4.2.1 Global Intramuscular Vaccine Adjuvants Revenue by Type (2020-2025)
4.2.2 Global Intramuscular Vaccine Adjuvants Revenue by Type (2026-2031)
4.2.3 Global Intramuscular Vaccine Adjuvants Revenue Market Share by Type (2020-2031)
4.3 Global Intramuscular Vaccine Adjuvants Price by Type (2020-2031)
5 Segment by Application
5.1 Global Intramuscular Vaccine Adjuvants Sales by Application (2020-2031)
5.1.1 Global Intramuscular Vaccine Adjuvants Sales by Application (2020-2025)
5.1.2 Global Intramuscular Vaccine Adjuvants Sales by Application (2026-2031)
5.1.3 Global Intramuscular Vaccine Adjuvants Sales Market Share by Application (2020-2031)
5.2 Global Intramuscular Vaccine Adjuvants Revenue by Application (2020-2031)
5.2.1 Global Intramuscular Vaccine Adjuvants Revenue by Application (2020-2025)
5.2.2 Global Intramuscular Vaccine Adjuvants Revenue by Application (2026-2031)
5.2.3 Global Intramuscular Vaccine Adjuvants Revenue Market Share by Application (2020-2031)
5.3 Global Intramuscular Vaccine Adjuvants Price by Application (2020-2031)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Company Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Intramuscular Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
6.1.4 GSK Intramuscular Vaccine Adjuvants Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 Dynavax Technologies
6.2.1 Dynavax Technologies Company Information
6.2.2 Dynavax Technologies Description and Business Overview
6.2.3 Dynavax Technologies Intramuscular Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Dynavax Technologies Intramuscular Vaccine Adjuvants Product Portfolio
6.2.5 Dynavax Technologies Recent Developments/Updates
6.3 Novavax
6.3.1 Novavax Company Information
6.3.2 Novavax Description and Business Overview
6.3.3 Novavax Intramuscular Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Novavax Intramuscular Vaccine Adjuvants Product Portfolio
6.3.5 Novavax Recent Developments/Updates
6.4 Agenus
6.4.1 Agenus Company Information
6.4.2 Agenus Description and Business Overview
6.4.3 Agenus Intramuscular Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Agenus Intramuscular Vaccine Adjuvants Product Portfolio
6.4.5 Agenus Recent Developments/Updates
6.5 Croda International
6.5.1 Croda International Company Information
6.5.2 Croda International Description and Business Overview
6.5.3 Croda International Intramuscular Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Croda International Intramuscular Vaccine Adjuvants Product Portfolio
6.5.5 Croda International Recent Developments/Updates
6.6 Seppic
6.6.1 Seppic Company Information
6.6.2 Seppic Description and Business Overview
6.6.3 Seppic Intramuscular Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Seppic Intramuscular Vaccine Adjuvants Product Portfolio
6.6.5 Seppic Recent Developments/Updates
6.7 OZ Biosciences
6.7.1 OZ Biosciences Company Information
6.7.2 OZ Biosciences Description and Business Overview
6.7.3 OZ Biosciences Intramuscular Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
6.7.4 OZ Biosciences Intramuscular Vaccine Adjuvants Product Portfolio
6.7.5 OZ Biosciences Recent Developments/Updates
6.8 Phibro Animal Health
6.8.1 Phibro Animal Health Company Information
6.8.2 Phibro Animal Health Description and Business Overview
6.8.3 Phibro Animal Health Intramuscular Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Phibro Animal Health Intramuscular Vaccine Adjuvants Product Portfolio
6.8.5 Phibro Animal Health Recent Developments/Updates
6.9 Associated British Foods
6.9.1 Associated British Foods Company Information
6.9.2 Associated British Foods Description and Business Overview
6.9.3 Associated British Foods Intramuscular Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Associated British Foods Intramuscular Vaccine Adjuvants Product Portfolio
6.9.5 Associated British Foods Recent Developments/Updates
6.10 InvivoGen
6.10.1 InvivoGen Company Information
6.10.2 InvivoGen Description and Business Overview
6.10.3 InvivoGen Intramuscular Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
6.10.4 InvivoGen Intramuscular Vaccine Adjuvants Product Portfolio
6.10.5 InvivoGen Recent Developments/Updates
6.11 Merck KGaA
6.11.1 Merck KGaA Company Information
6.11.2 Merck KGaA Description and Business Overview
6.11.3 Merck KGaA Intramuscular Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Merck KGaA Intramuscular Vaccine Adjuvants Product Portfolio
6.11.5 Merck KGaA Recent Developments/Updates
6.12 CSL Limited
6.12.1 CSL Limited Company Information
6.12.2 CSL Limited Description and Business Overview
6.12.3 CSL Limited Intramuscular Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
6.12.4 CSL Limited Intramuscular Vaccine Adjuvants Product Portfolio
6.12.5 CSL Limited Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Intramuscular Vaccine Adjuvants Industry Chain Analysis
7.2 Intramuscular Vaccine Adjuvants Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Intramuscular Vaccine Adjuvants Production Mode & Process Analysis
7.4 Intramuscular Vaccine Adjuvants Sales and Marketing
7.4.1 Intramuscular Vaccine Adjuvants Sales Channels
7.4.2 Intramuscular Vaccine Adjuvants Distributors
7.5 Intramuscular Vaccine Adjuvants Customer Analysis
8 Intramuscular Vaccine Adjuvants Market Dynamics
8.1 Intramuscular Vaccine Adjuvants Industry Trends
8.2 Intramuscular Vaccine Adjuvants Market Drivers
8.3 Intramuscular Vaccine Adjuvants Market Challenges
8.4 Intramuscular Vaccine Adjuvants Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
GSK
Dynavax Technologies
Novavax Inc
Agenus
Croda International
SEPPIC
Oz Biosciences
Phibro Animal Health
Associated British Foods
InvivoGen
Merck KGaA
CSL Limited
List of Tables
 Table 1. Global Intramuscular Vaccine Adjuvants Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Intramuscular Vaccine Adjuvants Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Intramuscular Vaccine Adjuvants Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Intramuscular Vaccine Adjuvants Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Intramuscular Vaccine Adjuvants Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Intramuscular Vaccine Adjuvants Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Intramuscular Vaccine Adjuvants Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Intramuscular Vaccine Adjuvants Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Intramuscular Vaccine Adjuvants, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Intramuscular Vaccine Adjuvants, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Intramuscular Vaccine Adjuvants, Product Type & Application
 Table 12. Global Key Manufacturers of Intramuscular Vaccine Adjuvants, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Intramuscular Vaccine Adjuvants by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intramuscular Vaccine Adjuvants as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Intramuscular Vaccine Adjuvants Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Intramuscular Vaccine Adjuvants Sales by Region (2020-2025) & (K Units)
 Table 18. Global Intramuscular Vaccine Adjuvants Sales Market Share by Region (2020-2025)
 Table 19. Global Intramuscular Vaccine Adjuvants Sales by Region (2026-2031) & (K Units)
 Table 20. Global Intramuscular Vaccine Adjuvants Sales Market Share by Region (2026-2031)
 Table 21. Global Intramuscular Vaccine Adjuvants Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Intramuscular Vaccine Adjuvants Revenue Market Share by Region (2020-2025)
 Table 23. Global Intramuscular Vaccine Adjuvants Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Intramuscular Vaccine Adjuvants Revenue Market Share by Region (2026-2031)
 Table 25. North America Intramuscular Vaccine Adjuvants Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Intramuscular Vaccine Adjuvants Sales by Country (2020-2025) & (K Units)
 Table 27. North America Intramuscular Vaccine Adjuvants Sales by Country (2026-2031) & (K Units)
 Table 28. North America Intramuscular Vaccine Adjuvants Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Intramuscular Vaccine Adjuvants Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Intramuscular Vaccine Adjuvants Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Intramuscular Vaccine Adjuvants Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Intramuscular Vaccine Adjuvants Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Intramuscular Vaccine Adjuvants Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Intramuscular Vaccine Adjuvants Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Intramuscular Vaccine Adjuvants Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Intramuscular Vaccine Adjuvants Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Intramuscular Vaccine Adjuvants Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Intramuscular Vaccine Adjuvants Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Intramuscular Vaccine Adjuvants Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Intramuscular Vaccine Adjuvants Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Intramuscular Vaccine Adjuvants Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Intramuscular Vaccine Adjuvants Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Intramuscular Vaccine Adjuvants Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Intramuscular Vaccine Adjuvants Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Intramuscular Vaccine Adjuvants Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Intramuscular Vaccine Adjuvants Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Intramuscular Vaccine Adjuvants Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Intramuscular Vaccine Adjuvants Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Intramuscular Vaccine Adjuvants Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Intramuscular Vaccine Adjuvants Sales (K Units) by Type (2020-2025)
 Table 51. Global Intramuscular Vaccine Adjuvants Sales (K Units) by Type (2026-2031)
 Table 52. Global Intramuscular Vaccine Adjuvants Sales Market Share by Type (2020-2025)
 Table 53. Global Intramuscular Vaccine Adjuvants Sales Market Share by Type (2026-2031)
 Table 54. Global Intramuscular Vaccine Adjuvants Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Intramuscular Vaccine Adjuvants Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Intramuscular Vaccine Adjuvants Revenue Market Share by Type (2020-2025)
 Table 57. Global Intramuscular Vaccine Adjuvants Revenue Market Share by Type (2026-2031)
 Table 58. Global Intramuscular Vaccine Adjuvants Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Intramuscular Vaccine Adjuvants Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Intramuscular Vaccine Adjuvants Sales (K Units) by Application (2020-2025)
 Table 61. Global Intramuscular Vaccine Adjuvants Sales (K Units) by Application (2026-2031)
 Table 62. Global Intramuscular Vaccine Adjuvants Sales Market Share by Application (2020-2025)
 Table 63. Global Intramuscular Vaccine Adjuvants Sales Market Share by Application (2026-2031)
 Table 64. Global Intramuscular Vaccine Adjuvants Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Intramuscular Vaccine Adjuvants Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Intramuscular Vaccine Adjuvants Revenue Market Share by Application (2020-2025)
 Table 67. Global Intramuscular Vaccine Adjuvants Revenue Market Share by Application (2026-2031)
 Table 68. Global Intramuscular Vaccine Adjuvants Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Intramuscular Vaccine Adjuvants Price (US$/Unit) by Application (2026-2031)
 Table 70. GSK Company Information
 Table 71. GSK Description and Business Overview
 Table 72. GSK Intramuscular Vaccine Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. GSK Intramuscular Vaccine Adjuvants Product
 Table 74. GSK Recent Developments/Updates
 Table 75. Dynavax Technologies Company Information
 Table 76. Dynavax Technologies Description and Business Overview
 Table 77. Dynavax Technologies Intramuscular Vaccine Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Dynavax Technologies Intramuscular Vaccine Adjuvants Product
 Table 79. Dynavax Technologies Recent Developments/Updates
 Table 80. Novavax Company Information
 Table 81. Novavax Description and Business Overview
 Table 82. Novavax Intramuscular Vaccine Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Novavax Intramuscular Vaccine Adjuvants Product
 Table 84. Novavax Recent Developments/Updates
 Table 85. Agenus Company Information
 Table 86. Agenus Description and Business Overview
 Table 87. Agenus Intramuscular Vaccine Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Agenus Intramuscular Vaccine Adjuvants Product
 Table 89. Agenus Recent Developments/Updates
 Table 90. Croda International Company Information
 Table 91. Croda International Description and Business Overview
 Table 92. Croda International Intramuscular Vaccine Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Croda International Intramuscular Vaccine Adjuvants Product
 Table 94. Croda International Recent Developments/Updates
 Table 95. Seppic Company Information
 Table 96. Seppic Description and Business Overview
 Table 97. Seppic Intramuscular Vaccine Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Seppic Intramuscular Vaccine Adjuvants Product
 Table 99. Seppic Recent Developments/Updates
 Table 100. OZ Biosciences Company Information
 Table 101. OZ Biosciences Description and Business Overview
 Table 102. OZ Biosciences Intramuscular Vaccine Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. OZ Biosciences Intramuscular Vaccine Adjuvants Product
 Table 104. OZ Biosciences Recent Developments/Updates
 Table 105. Phibro Animal Health Company Information
 Table 106. Phibro Animal Health Description and Business Overview
 Table 107. Phibro Animal Health Intramuscular Vaccine Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Phibro Animal Health Intramuscular Vaccine Adjuvants Product
 Table 109. Phibro Animal Health Recent Developments/Updates
 Table 110. Associated British Foods Company Information
 Table 111. Associated British Foods Description and Business Overview
 Table 112. Associated British Foods Intramuscular Vaccine Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Associated British Foods Intramuscular Vaccine Adjuvants Product
 Table 114. Associated British Foods Recent Developments/Updates
 Table 115. InvivoGen Company Information
 Table 116. InvivoGen Description and Business Overview
 Table 117. InvivoGen Intramuscular Vaccine Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. InvivoGen Intramuscular Vaccine Adjuvants Product
 Table 119. InvivoGen Recent Developments/Updates
 Table 120. Merck KGaA Company Information
 Table 121. Merck KGaA Description and Business Overview
 Table 122. Merck KGaA Intramuscular Vaccine Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Merck KGaA Intramuscular Vaccine Adjuvants Product
 Table 124. Merck KGaA Recent Developments/Updates
 Table 125. CSL Limited Company Information
 Table 126. CSL Limited Description and Business Overview
 Table 127. CSL Limited Intramuscular Vaccine Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. CSL Limited Intramuscular Vaccine Adjuvants Product
 Table 129. CSL Limited Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Intramuscular Vaccine Adjuvants Distributors List
 Table 133. Intramuscular Vaccine Adjuvants Customers List
 Table 134. Intramuscular Vaccine Adjuvants Market Trends
 Table 135. Intramuscular Vaccine Adjuvants Market Drivers
 Table 136. Intramuscular Vaccine Adjuvants Market Challenges
 Table 137. Intramuscular Vaccine Adjuvants Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Intramuscular Vaccine Adjuvants
 Figure 2. Global Intramuscular Vaccine Adjuvants Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Intramuscular Vaccine Adjuvants Market Share by Type: 2024 & 2031
 Figure 4. Infectious Diseases Product Picture
 Figure 5. Cancer Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Intramuscular Vaccine Adjuvants Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Intramuscular Vaccine Adjuvants Market Share by Application: 2024 & 2031
 Figure 9. Research Applications
 Figure 10. Commercial Applications
 Figure 11. Global Intramuscular Vaccine Adjuvants Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Intramuscular Vaccine Adjuvants Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Intramuscular Vaccine Adjuvants Sales (2020-2031) & (K Units)
 Figure 14. Global Intramuscular Vaccine Adjuvants Average Price (US$/Unit) & (2020-2031)
 Figure 15. Intramuscular Vaccine Adjuvants Report Years Considered
 Figure 16. Intramuscular Vaccine Adjuvants Sales Share by Manufacturers in 2024
 Figure 17. Global Intramuscular Vaccine Adjuvants Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Intramuscular Vaccine Adjuvants Players: Market Share by Revenue in Intramuscular Vaccine Adjuvants in 2024
 Figure 19. Intramuscular Vaccine Adjuvants Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Intramuscular Vaccine Adjuvants Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Intramuscular Vaccine Adjuvants Sales Market Share by Country (2020-2031)
 Figure 22. North America Intramuscular Vaccine Adjuvants Revenue Market Share by Country (2020-2031)
 Figure 23. United States Intramuscular Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Intramuscular Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Intramuscular Vaccine Adjuvants Sales Market Share by Country (2020-2031)
 Figure 26. Europe Intramuscular Vaccine Adjuvants Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Intramuscular Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Intramuscular Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Intramuscular Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Intramuscular Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Intramuscular Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Intramuscular Vaccine Adjuvants Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Intramuscular Vaccine Adjuvants Revenue Market Share by Region (2020-2031)
 Figure 34. China Intramuscular Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Intramuscular Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Intramuscular Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Intramuscular Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Intramuscular Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Intramuscular Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Intramuscular Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Intramuscular Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Intramuscular Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Intramuscular Vaccine Adjuvants Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Intramuscular Vaccine Adjuvants Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Intramuscular Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Intramuscular Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Intramuscular Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Intramuscular Vaccine Adjuvants Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Intramuscular Vaccine Adjuvants Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Intramuscular Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Intramuscular Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Intramuscular Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Intramuscular Vaccine Adjuvants by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Intramuscular Vaccine Adjuvants by Type (2020-2031)
 Figure 55. Global Intramuscular Vaccine Adjuvants Price (US$/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Intramuscular Vaccine Adjuvants by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Intramuscular Vaccine Adjuvants by Application (2020-2031)
 Figure 58. Global Intramuscular Vaccine Adjuvants Price (US$/Unit) by Application (2020-2031)
 Figure 59. Intramuscular Vaccine Adjuvants Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Global Subcutaneous Vaccine Adjuvants Market Research Report 2025
Global Biological Vaccines Adjuvants Market Research Report 2025
Immunostimulatory Adjuvants Market
Human Vaccine Adjuvants Market
Global Oral Vaccine Adjuvants Market Research Report 2025
Veterinary Vaccine Adjuvants Market
Global Immune Adjuvant Market Research Report 2024
Intramuscular Injector Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Intramuscular Drug Delivery Market
Animal Vaccine Adjuvant Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Intramuscular Drug Delivery Equipment Market Research Report 2025
Global Adjuvant Therapy Market Research Report 2024
Global Mineral based Adjuvants Market Research Report 2024
Global Vaccine Particulate Adjuvants Market Research Report 2025
Global Adjuvanted Influenza Vaccine Market Research Report 2024
Global Intramuscular HPV Vaccine Market Research Report 2024
Global Adjuvants in Agriculture Market Research Report 2024
Aluminum based Vaccine Adjuvant Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Intramuscular Injectable Suspensions Market Research Report 2024
Global Noninvasive Delivery Vaccine Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions